1-甲基-1,2,3,4-四氢异喹啉二盐酸盐
|
K036738-250mg
|
97% |
1259952-24-3 |
250mg
|
¥ 660.0
|
5-7天 |
科威 |
1-甲基-1,2,3,4-四氢异喹啉二盐酸盐
|
K036738-50mg
|
97% |
1259952-24-3 |
50mg
|
¥ 220.0
|
5-7天 |
科威 |
(R)-3-氧代-5-羟基-6-氰基己酸叔丁酯
|
K036737-1g
|
≥95% |
125988-01-4 |
1g
|
¥ 5707.0
|
5-7天 |
科威 |
(R)-3-氧代-5-羟基-6-氰基己酸叔丁酯
|
K036737-250mg
|
≥95% |
125988-01-4 |
250mg
|
¥ 2378.0
|
5-7天 |
科威 |
tert-丁基(4R,3R)-6-cyano甲基-2,2-二甲基-1,3-二氧杂环乙烷-4-乙酸,
|
K036736-25ml
|
97 % |
125971-94-0 |
25ml
|
¥ 275.0
|
5-7天 |
科威 |
2,3-二氨基-5-氯吡嗪
|
K036735-250mg
|
98% |
1259479-81-6 |
250mg
|
¥ 2329.0
|
5-7天 |
科威 |
2,3-二氨基-5-氯吡嗪
|
K036735-50mg
|
98% |
1259479-81-6 |
50mg
|
¥ 776.0
|
5-7天 |
科威 |
(1S,3R)-3-氨基环戊醇盐酸盐
|
K036734-100mg
|
97% |
1259436-59-3 |
100mg
|
¥ 1371.0
|
5-7天 |
科威 |
(1S,3R)-3-氨基环戊醇盐酸盐
|
K036734-25mg
|
97% |
1259436-59-3 |
25mg
|
¥ 571.0
|
5-7天 |
科威 |
1-(4-氨基苯基)环丁基氨基甲酸叔丁酯
|
K036733-100mg
|
96% |
1259224-00-4 |
100mg
|
¥ 702.0
|
5-7天 |
科威 |
1-(4-氨基苯基)环丁基氨基甲酸叔丁酯
|
K036733-25mg
|
96% |
1259224-00-4 |
25mg
|
¥ 292.0
|
5-7天 |
科威 |
6-(4-氯苯基)吡嗪-2-甲酸
|
K036732-1g
|
95% |
1258850-50-8 |
1g
|
¥ 3566.0
|
5-7天 |
科威 |
6-(4-氯苯基)吡嗪-2-甲酸
|
K036732-250mg
|
95% |
1258850-50-8 |
250mg
|
¥ 1617.0
|
5-7天 |
科威 |
(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K036731-100mg
|
≥98%,99%e.e. |
1258327-08-0 |
100mg
|
¥ 5403.0
|
5-7天 |
科威 |
(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K036730-100mg
|
≥98%,99%e.e. |
1258327-07-9 |
100mg
|
¥ 5197.0
|
5-7天 |
科威 |
(11aS)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K036729-100mg
|
≥98%,99%e.e. |
1258327-06-8 |
100mg
|
¥ 5505.0
|
5-7天 |
科威 |
(11aS)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K036729-50mg
|
≥98%,99%e.e. |
1258327-06-8 |
50mg
|
¥ 3854.0
|
5-7天 |
科威 |
(11aS)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K036728-100mg
|
≥95%,99%e.e. |
1258327-05-7 |
100mg
|
¥ 5011.0
|
5-7天 |
科威 |
(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K036727-100mg
|
≥98%,99%e.e. |
1258327-04-6 |
100mg
|
¥ 4899.0
|
5-7天 |
科威 |
(S)-螺环二酚膦酸酯
|
K036726-100mg
|
≥98%,99%e.e. |
1258327-03-5 |
100mg
|
¥ 1399.0
|
5-7天 |
科威 |
(S)-2,2',3,3'-Tetrahydro-6,6'-di(1-naphthalenyl)-1,1'-spirobi[1H-indene]-7,7'-diol
|
K036725-100mg
|
≥98%,99%e.e. |
1258327-02-4 |
100mg
|
¥ 4211.0
|
5-7天 |
科威 |
(S)-6,6'-Bis[3,5-bis(trifluoromethyl)phenyl]-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diol
|
K036724-100mg
|
≥98%,99%e.e. |
1258327-01-3 |
100mg
|
¥ 4078.0
|
5-7天 |
科威 |
(S)-6,6'-Bis([1,1'-biphenyl]-4-yl)-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diol
|
K036723-100mg
|
≥98%,99%e.e. |
1258327-00-2 |
100mg
|
¥ 5571.0
|
5-7天 |
科威 |
(S)-6,6'-Bis(4-chlorophenyl)-2,2',3,3'-tetrahydro-1,1'spirobi[1H-indene]-7,7'-diol
|
K036722-100mg
|
≥98%,99%e.e. |
1258326-99-6 |
100mg
|
¥ 3761.0
|
5-7天 |
科威 |